While cannabidiol (CBD) is fast becoming a common compound for pain and anxiety relief, the exact pathways and dosage have remained elusive. A recent study, published in the journal PAIN, identified new pathways, beyond the endocannabinoid system, which explain its analgesic and anti-anxiety benefits. They are surprisingly different than whatRead
BALA CYNWYD, Pa., Oct. 16, 2018 — Dr. Sanjay Gupta, President of the American Pain Association (APA)* and a pain management specialist based in Bala Cynwyd, Penn., is leading the push for insurance companies to cover cannabidiol (CBD) products for the treatment of pain and Opioid Use Disorder. Simply put,Read
In these two videos, Derrick DeSilva, MD, discusses the value of full-spectrum hemp to address pain and inflammation. As he explains, full-spectrum hemp (FSH) has a novel dual mechanism of Cox-2 and Lox-5, similar to turmeric, to address pain. What you will learn: What are the mechanisms that addresses inflammationRead
As part of our ongoing series on full-spectrum hemp, Dr. DeSilva and Today’s Practitioner’s Rob Lutz discusses the endocannabinoid system, hemp’s role as an adaptogen, what is the dosage for full-spectrum hemp?, along with many other pearls of wisdom. Click here for Part 1 & 2, Clinical Fundamentals of Full-SpectrumRead
Full-spectrum hemp is gaining a remarkable reputation among clinicians as a fundamental and safe botanical for a variety of clinical purposes. In these short videos, Derrick DeSilva, MD and Rob Lutz, founder of Today’s Practitioner, reviews the safety, side effects and clinical uses of full-spectrum hemp (cannabidiol). What you willRead
In this podcast Micheal Ruscio, DC interviews Chris Meletis, ND on how to safely and effectively utilize cannabidiol (CBD) and medical cannabis in your practice. Most recently Dr. Meletis was featured in the Townsend Letter on a new medical certification program for practitioners prescribing CBD and other active constituents ofRead
Eureka! We’ve been on the search and finally found a refreshingly honest interview on the subject of the endocannabinoid system and the use of cannabidiol in clinical practice. Not surprisingly, it came from Carl Germano, PhD, RD, CNS, CDN. Germano has been in private practice in integrative and nutritional therapiesRead
Could non-psychoactive hemp be a viable use to reduce ovarian cancer risk? As we learn more about the bioactives in hemp, the possibility becomes ever real. At the 2018 annual Experimental Biology meeting in San Diego, graduate students, Sara Biela and Chase Turner, presented the first study to examine hemp andRead
This video, Jeffrey Chen, MD, the Director of the UCLA Cannabis Research Initiative, is the best explanation of the mechanisms and action potential of endocannabinoids in the human body. This is followed by and interview with Raphael Mechoulan, PhD, professor of Medicinal Chemistry at the Hebrew University of Jerusalem. MechoulanRead
Have you been hesitant to prescribe cannabidiol (CBD) because of concerns about gastric acids converting the CBD into psychoactive tetrahydrocannabinol (THC)? In 2016, a study by Merrick et al. suggested that when CBD is exposed to an acidic environment, it degrades to Δ9-tetrahydrocannabinol and other psychoactive cannabinoids. The following isRead
